This article is more than 6 month old.

COVID-19 vaccine race: Bharat Biotech seeks emergency use authorisation for Covaxin from DCGI

Mini

Sources told CNBC-TV18 that Bharat Biotech has filed an application with the DCGI seeking emergency use authorisation for Covaxin.

COVID-19 vaccine race: Bharat Biotech seeks emergency use authorisation for Covaxin from DCGI
After Pfizer and Serum Institute of India, Bharat Biotech has become the third pharma major to seek a nod from Drug Controller General of India (DCGI) for emergency use authorisation for its COVID-19 vaccine, Covaxin.
Sources told CNBC-TV18 that Bharat Biotech has filed an application with the DCGI seeking emergency use authorisation for Covaxin.
Pfizer and Serum Institute sought emergency use authorisation on December 5 and 6, respectively. Sources said that an internal review of the applications had commenced under the accelerated review process, which is likely to conclude within two weeks.
"The Drug Controller General of India is likely to look into these applications under the accelerated review process for granting emergency use authorisation, and an outcome is expected over the next two weeks," sources said.

Market Movers

CompanyPriceChange%Loss
ONGC120.25 -4.85
Coal India146.40 -5.75
JSW Steel670.60 -25.75
NTPC113.55 -3.85
UPL808.00 -27.05
CompanyPriceChange%Loss
ONGC120.35 -4.65
NTPC113.55 -3.70
M&M784.85 -20.60
Power Grid Corp233.00 -6.70
Nestle17,678.30 -375.20
CompanyPriceChange%Loss
ONGC120.25 -4.85 -3.88
Coal India146.40 -5.75 -3.78
JSW Steel670.60 -25.75 -3.70
NTPC113.55 -3.85 -3.28
UPL808.00 -27.05 -3.24
CompanyPriceChange%Loss
ONGC120.35 -4.65 -3.72
NTPC113.55 -3.70 -3.16
M&M784.85 -20.60 -2.56
Power Grid Corp233.00 -6.70 -2.80
Nestle17,678.30 -375.20 -2.08

Currency

CompanyPriceChng%Chng
Dollar-Rupee73.8600-0.2175-0.29
Euro-Rupee87.8770-0.4200-0.48
Pound-Rupee102.2970-0.9290-0.90
Rupee-100 Yen0.6699-0.0019-0.29